These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1908891)
21. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)]. Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810 [TBL] [Abstract][Full Text] [Related]
22. Observations on serial radionuclide blood-flow studies in Paget's disease: concise communication. Boudreau RJ; Lisbona R; Hadjipavlou A J Nucl Med; 1983 Oct; 24(10):880-5. PubMed ID: 6225840 [TBL] [Abstract][Full Text] [Related]
23. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate. Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414 [TBL] [Abstract][Full Text] [Related]
24. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915 [TBL] [Abstract][Full Text] [Related]
25. Extensive visceral calcification demonstrated on Tc-99m MDP bone scan in patient with sphenoidal sinus carcinoma and hypercalcaemia of malignancy: a bad prognostic sign. Usmani S; Khan HA; Abu Huda F; Al Nafisi N; Al Mohannadi S Gulf J Oncolog; 2011 Jan; (9):61-4. PubMed ID: 21177211 [TBL] [Abstract][Full Text] [Related]
26. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes. Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385 [TBL] [Abstract][Full Text] [Related]
27. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease]. Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124 [TBL] [Abstract][Full Text] [Related]
28. Hypercalcemia with extraosseous MDP uptake in a bone scan as initial presentation in a case of cutaneous T-cell lymphoma. Palaniswamy SS; Padma S; Harish V; Rai JK J Cancer Res Ther; 2011; 7(1):72-4. PubMed ID: 21546747 [TBL] [Abstract][Full Text] [Related]
29. Intestinal leakage of technetium-99m-MDP in primary intestinal lymphangiectasia. Lee KH; Chung JK; Lee DS; Lee MC; Song IS; Koh CS J Nucl Med; 1996 Apr; 37(4):639-41. PubMed ID: 8691257 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring can avoid iatrogenic alterations caused by 99mTc-methylene diphosphonate (MDP)-gentamicin interaction. Chen WL; Perng MY; Hwei DZ; Yu MD J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):132-4. PubMed ID: 7632757 [TBL] [Abstract][Full Text] [Related]
31. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review. Kaye J; Hayward M Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582 [TBL] [Abstract][Full Text] [Related]
32. Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast. Zhang W; Chen B; Deng H; Yang T; Ou X Clin Nucl Med; 2013 Mar; 38(3):219-20. PubMed ID: 23412599 [TBL] [Abstract][Full Text] [Related]
33. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy]. Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760 [TBL] [Abstract][Full Text] [Related]
34. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608 [No Abstract] [Full Text] [Related]
35. Diffuse hepatic uptake of (99m)Tc methylene diphosphonate on bone scintigraphy in a case of hypercalcemia and diffuse large B cell lymphoma. Qiu ZL; Xue YL; Song HJ; Luo QY Hell J Nucl Med; 2013; 16(1):66-7. PubMed ID: 23789120 [No Abstract] [Full Text] [Related]
36. [Treatment of hypercalcemia of tumoral origin with two diphosphonates]. Jung A; van Ouwenaller C; Chantraine A; Courvoisier B Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698 [TBL] [Abstract][Full Text] [Related]
37. Diffuse abdominal uptake of technetium-99m-methylene diphosphonate in a patient on continuous ambulatory dialysis during bone scintigraphy. McDevitt GR; Heironimus JD; Toney MO; Billingsley JL J Nucl Med; 1992 Nov; 33(11):2052-4. PubMed ID: 1432173 [TBL] [Abstract][Full Text] [Related]
39. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy. Goldman AB; Braunstein P; Wilkinson D; Kammerman S Radiology; 1975 Nov; 117(2):365-9. PubMed ID: 809805 [TBL] [Abstract][Full Text] [Related]
40. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study. Macro M; Bouvard G; Le Gangneux E; Colin T; Loyau G Rev Rhum Engl Ed; 1995 Feb; 62(2):99-104. PubMed ID: 7600079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]